Nvidia Corp (NASDAQ:NVDA, XETRA:NVD) delivered another blockbuster quarter on Wednesday, blowing past Wall Street expectations as demand for artificial intelligence (AI) chips continues to soar.
The chipmaker reported fourth-quarter revenue of $68.13 billion, topping analyst estimates of $65.91 billion and marking a 73% increase from a year earlier.
Salesforce Inc (NYSE:CRM, XETRA:FOO) shares fell more than 4% afterhours on Wednesday as the cloud software company reported better-than-expected quarterly results but issued a fiscal 2027 outlook that came in slightly below Wall Street expectations on revenue.
For the fourth quarter, Salesforce reported adjusted earnings per share of $3.81, topping the $3.04 expected by analysts.
Bank of America has downgraded Molson Coors Beverage Co (NYSE:TAP) to ‘Underperform’ from ‘Neutral’ and lowered its price target to $42 from $50, following the company's fourth quarter 2025 results and its presentation at the recent CAGNY conference.
"Our downgrade reflects rising downside risk to forward estimates should the US beer category experience another year of mid‑single‑digit declines or TAP's consumption trend meaningfully underperform the category,” the analysts wrote.
Circle Internet Group (NYSE:CRCL), the issuer of the world’s second-largest stablecoin, saw its shares surge 23% on Wednesday after reporting a strong fourth-quarter profit, driven by growing demand for its USDC stablecoin.
The company posted revenue of $770 million, beating analyst estimates of $744 million and marking a 77% increase from a year earlier. Adjusted earnings per share came in at $0.43, well above expectations of $0.16, while adjusted EBITDA reached $167 million, reflecting a margin of 54%.
Cava (NYSE:CAVA) saw its shares rise sharply after reporting fiscal fourth quarter results that exceeded Wall Street expectations and issuing a positive growth forecast for 2026.
For the quarter ended December 28, the fast-casual Mediterranean chain posted earnings per share of $0.04, above analysts’ estimates of $0.03.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said new biomarker data from an expanded-access program showed its experimental intranasal therapy reduced brain inflammation and was associated with neuroprotective changes in patients with a progressive form of multiple sclerosis.
The late-breaking findings were presented by investigators from Brigham and Women’s Hospital in a poster detailing results in 10 patients with non-active secondary progressive multiple sclerosis (na-SPMS) with progression independent of relapse activity (PIRA).
Lowe's Companies Inc (NYSE:LOW) reported fourth quarter and full-year results for fiscal 2025 this morning, posting stronger-than-expected earnings for the holiday quarter but offering a conservative outlook for 2026.
Shares traded down almost 5% in early trading following the report.
A weak cold and flu season and a cautious American consumer pushed organic growth to 3%, a full percentage point below the floor of what Haleon has promised investors
Haleon PLC (LSE:HLN, NYSE:HLN) shares fell 3.4% to 392.1p on Wednesday after the consumer health group reported full-year organic revenue growth of 3%, missing the 4-6% medium-term range it has set as its benchmark and leaving investors to weigh whether the shortfall reflects bad luck or something more structural.